Bribery by GSK China was coordinated at company level: Xinhua
SHANGHAI (REUTERS) - A Chinese police investigation into drugmaker GlaxoSmithKline has discovered that alleged bribery of doctors in China was coordinated by the British company and was not the work of individual employees, state media reported on Tuesday.
Police in July detained four senior Chinese executives at GSK over allegations the company funnelled up to 3 billion yuan (S$ 626 million) to travel agencies to facilitate bribes to doctors and officials to boost the sale of its medicines.
"It is becoming clear that it is organised by GSK China rather than ... sales people's individual behaviour," the official Xinhua news agency reported.
GSK officials could not be reached for comment.